PTPRC and acute lymphoblastic leukemia: To date, results issued from this clinical phase I/II study enrolling patients with acute myeloid leukemia and acute lymphoblastic leukemia for treatment with an anti-CD45 antibody, 211At-BC8-B10, before donor stem cell transplant, have not yet been published.